Failure by the importer or distributor of a device to immediately inform the Agence nationale de sécurité du médicament et des produits de santé, pursuant to Article 13(7) of Regulation (EU) 2017/745 or Article 14(4) of the same Regulation, that the device it has placed on the market, put into service or made available on French territory presents a serious risk or is a falsified device, is punishable by one year’s imprisonment and a fine of €150,000.